GlobeNewsWire
02 Oct 2026, 10:50 UTC · 7h ago
Verdict
Headline leans bearish. We score HIMS −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 2 new · 1 priced in
The FTC filed a lawsuit against Hims & Hers on July 29, 2026, alleging the company shared sensitive health data with advertising platforms like Meta and Snap and deceived users regarding billing.
Priced inevent occurred July 29, 2026
So whatThe shares already declined nearly 15% on this specific news, meaning any further movement depends on the scale of potential FTC penalties.
More negative than 95% of claims this week
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Hims & Hers and its executives for alleged violations of the Securities Exchange Act of 1934.
Newannounces Oct 02, 2026
So whatLegal costs and potential settlements from securities litigation can create multi-year drags on EPS and cash reserves.
More negative than 78% of claims this week
Investors who acquired HIMS securities between August 4, 2025 and July 29, 2026 have until November 2, 2026 to apply to be lead plaintiff.
Newannounces Oct 02, 2026
More negative than 64% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a class action lawsuit and an FTC complaint alleging deceptive billing and privacy violations, leading to a share price drop.
More negative than 64% of ticker scores this week
Mentioned as a third-party platform that received sensitive health information from Hims & Hers, potentially linking it to a regulatory probe.
More negative than 64% of ticker scores this week
Mentioned as a third-party platform that received sensitive health information from Hims & Hers, potentially linking it to a regulatory probe.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
More positive than 15% of relationship scores this week
[a_to_b] Hims & Hers shared consumer health information with Snap's advertising platform.
−1.5%
Price agrees with the score
$28.85 vs $29.30 close before publication (Oct 1) · not market-adjusted
HIMS chart →
